<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/Organization>
<http://www.news-medical.net/news/20121210/Ipsen-Active-Biotech-complete-enrollment-in-tasquinimod-Phase-III-trial-for-prostate-cancer.aspx>